MC-0518
- Generic Name
- MC-0518
Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants with Steroid-Refractory Acute Graft Versus Host Disease
Phase 2
Recruiting
- Conditions
- Steroid-refractory Acute Graft-versus-host Disease
- Interventions
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT06075706
- Locations
- π«π·
CHU de Bordeaux - Hopital des Enfants, Bordeaux, France
π«π·CHU de Marseille-Hopital de la Timone, Marseille, France
π«π·CHU Grenoble Alpes - Hopital Couple Enfant (HCE), La Tronche, France
Treatment of Steroid-Refractory Acute Graft-versus-host Disease with Mesenchymal Stromal Cells Versus Best Available Therapy
Phase 3
Recruiting
- Conditions
- Steroid-refractory Acute Graft-versus-host Disease
- Interventions
- First Posted Date
- 2020-11-16
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 210
- Registration Number
- NCT04629833
- Locations
- π«π·
Centre Hospitalier Universitaire (CHU) Amiens-Picardie - Hopital Sud, Amiens, France
π«π·CHU Jean Minjoz, Besancon, France
π«π·CHU de Nantes - Hotel Dieu, Nantes, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath